Management and outcomes of paediatric patients on emicizumab prophylaxis undergoing surgical procedures: Experience from a large haemophilia centre in the UK
Haemophilia
.
2021 Sep;27(5):e620-e623.
doi: 10.1111/hae.14358.
Epub 2021 Jun 12.
Authors
Eman Hassan
1
2
,
Jayashree Motwani
1
Affiliations
1
Department of Paediatric Haematology, Birmingham Children's Hospital, Birmingham, UK.
2
Department of Pediatrics, Haematology and Oncology Unit, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
PMID:
34118116
DOI:
10.1111/hae.14358
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Bispecific*
Antibodies, Monoclonal, Humanized / therapeutic use
Child
Hemophilia A* / drug therapy
Humans
United Kingdom
Substances
Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
emicizumab